Search Results - "Zanger, Ulrich M"

Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance by Zanger, Ulrich M, Klein, Kathrin

“…Cytochrome P450 2B6 (CYP2B6) belongs to the minor drug metabolizing P450s in human liver. Expression is highly variable both between individuals and within…”
Get full text

MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation by Kugler, Nicole, Klein, Kathrin, Zanger, Ulrich M.

“…[Display omitted] In conditions of acute and chronic inflammation hepatic detoxification capacity is severely impaired due to coordinated downregulation of…”
Get full text

Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the "Missing Heritability" Problem by Klein, Kathrin, Zanger, Ulrich M

“…CYP3A4 is the most important drug metabolizing enzyme in adult humans because of its prominent expression in liver and gut and because of its broad substrate…”
Get full text

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation by Zanger, Ulrich M, Turpeinen, Miia, Klein, Kathrin, Schwab, Matthias

“…We investigated the elimination routes for the 200 drugs that are sold most often by prescription count in the United States. The majority (78%) of the…”
Get full text

Tri‐Allelic Haplotypes Determine and Differentiate Functionally Normal Allele CYP2D62 and Impaired Allele CYP2D641 by Zanger, Ulrich M., Momoi, Kyoko, Hofmann, Ute, Schwab, Matthias, Klein, Kathrin

“…CYP2D6 metabolizes 20–25% of all clinically used drugs and its complex genetic polymorphism is a major determinant of drug safety and efficacy. We investigated…”
Get full text

Breast Cancer Treatment Outcome With Adjuvant Tamoxifen Relative to Patient CYP2D6 and CYP2C19 Genotypes by SCHROTH, Werner, ANTONIADOU, Lydia, FRITZ, Peter, SCHWAB, Matthias, MUERDTER, Thomas, ZANGER, Ulrich M, SIMON, Wolfgang, EICHELBAUM, Michel, BRAUCH, Hiltrud

“…The clinical outcome of tamoxifen-treated breast cancer patients may be influenced by the activity of cytochrome P450 enzymes that catalyze the formation of…”
Get full text

Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver by Nies, Anne T., Koepsell, Hermann, Winter, Stefan, Burk, Oliver, Klein, Kathrin, Kerb, Reinhold, Zanger, Ulrich M., Keppler, Dietrich, Schwab, Matthias, Schaeffeler, Elke

“…An important function of hepatocytes is the biotransformation and elimination of various drugs, many of which are organic cations and are taken up by organic…”
Get full text

A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cells by Klein, Marcus, Thomas, Maria, Hofmann, Ute, Seehofer, Daniel, Damm, Georg, Zanger, Ulrich M

“…Inflammatory processes are associated with compromised metabolism and elimination of drugs in the liver, largely mediated by proinflammatory cytokines, such as…”
Get full text

Inflammation-associated microRNA-130b down-regulates cytochrome P450 activities and directly targets CYP2C9 by Rieger, Jessica K, Reutter, Sandra, Hofmann, Ute, Schwab, Matthias, Zanger, Ulrich M

“…Expression of genes involved in absorption, distribution, metabolism, and excretion (ADME) of drugs is impaired in pathophysiologic conditions such as…”
Get full text

Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression by Asperger, Hannah, Stamm, Nadia, Gierke, Berthold, Pawlak, Michael, Hofmann, Ute, Zanger, Ulrich M, Marton, Annamaria, Katona, Robert L, Buhala, Andrea, Vizler, Csaba, Cieslik, Jan-Philipp, Ruckhäberle, Eugen, Niederacher, Dieter, Fehm, Tanja, Neubauer, Hans, Ludescher, Marina

“…PGRMC1 (progesterone receptor membrane component 1) is a highly conserved heme binding protein, which is overexpressed especially in hormone receptor-positive…”
Get full text

Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group by SCHWAB, Matthias, ZANGER, Ulrich M, BOKEMEYER, Carsten, EICHELBAUM, Michel, MARX, Claudia, SCHAEFFELER, Elke, KLEIN, Kathrin, DIPPON, Jürgen, KERB, Reinhold, BLIEVERNICHT, Julia, FISCHER, Joachim, HOFMANN, Ute

“…To assess the predictive value of polymorphisms in dihydropyrimidine dehydrogenase (DPYD ), thymidylate synthase (TYMS ), and methylene tetrahydrofolate…”
Get full text

Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cells by Heintze, Tamara, Klein, Kathrin, Hofmann, Ute, Zanger, Ulrich M.

“…HepaRG cells are increasingly accepted as model for human drug metabolism and other hepatic functions. We used lentiviral transduction of undifferentiated…”
Get full text

Polycyclic Aromatic Hydrocarbons Activate the Aryl Hydrocarbon Receptor and the Constitutive Androstane Receptor to Regulate Xenobiotic Metabolism in Human Liver Cells by Goedtke, Lisa, Sprenger, Heike, Hofmann, Ute, Schmidt, Felix F, Hammer, Helen S, Zanger, Ulrich M, Poetz, Oliver, Seidel, Albrecht, Braeuning, Albert, Hessel-Pras, Stefanie

“…Polycyclic aromatic hydrocarbons (PAHs) are environmental pollutants produced by incomplete combustion of organic matter. They induce their own metabolism by…”
Get full text

Transcriptional profiling of human liver identifies sex-biased genes associated with polygenic dyslipidemia and coronary artery disease by Zhang, Yijing, Klein, Kathrin, Sugathan, Aarathi, Nassery, Najlla, Dombkowski, Alan, Zanger, Ulrich M, Waxman, David J

“…Sex-differences in human liver gene expression were characterized on a genome-wide scale using a large liver sample collection, allowing for detection of small…”
Get full text

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry by Zanger, Ulrich M, Raimundo, Sebastian, Eichelbaum, Michel

“…Of about one dozen human P450 s that catalyze biotransformations of xenobiotics, CYP2D6 is one of the more important ones based on the number of its drug…”
Get full text

Role of ABC Transporters in Fluoropyrimidine-Based Chemotherapy Response by Nies, Anne T, Magdy, Tarek, Schwab, Matthias, Zanger, Ulrich M

“…Since over 50 years, 5-fluorouracil (5-FU) is in use as backbone of chemotherapy treatment regimens for a wide range of cancers including colon, breast, and…”
Get full text

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation by ZANGER, Ulrich M, SCHWAB, Matthias

“…Cytochromes P450 (CYP) are a major source of variability in drug pharmacokinetics and response. Of 57 putatively functional human CYPs only about a dozen…”
Get full text

Model-Based Characterization of Inflammatory Gene Expression Patterns of Activated Macrophages by Rex, Julia, Albrecht, Ute, Ehlting, Christian, Thomas, Maria, Zanger, Ulrich M, Sawodny, Oliver, Häussinger, Dieter, Ederer, Michael, Feuer, Ronny, Bode, Johannes G

“…Macrophages are cells with remarkable plasticity. They integrate signals from their microenvironment leading to context-dependent polarization into classically…”
Get full text

Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B66, is responsible for decreased expression and activity of CYP2B6 in liver by Hofmann, Marco H, Blievernicht, Julia K, Klein, Kathrin, Saussele, Tanja, Schaeffeler, Elke, Schwab, Matthias, Zanger, Ulrich M

“…CYP2B6 is a polymorphic human drug metabolizing cytochrome P450 with clinical relevance for several drug substrates including cyclophosphamide, bupropion, and…”
Get more information

Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα) by Thomas, Maria, Burk, Oliver, Klumpp, Britta, Kandel, Benjamin A, Damm, Georg, Weiss, Thomas S, Klein, Kathrin, Schwab, Matthias, Zanger, Ulrich M

“…The nuclear receptor peroxisome proliferator-activated receptor (PPAR)α is known primarily as a regulator of fatty acid metabolism, energy balance, and…”
Get more information